Saturday 17 October 2026 Export AUPH’s income statement to Excel — free account

Aurinia Pharmaceuticals Inc

Aurinia Pharmaceuticals Inc’s revenue for fiscal 2025 (year ended December 2025) was $283.1 million, up 20.4% from fiscal 2024. In the quarter to June 2026, revenue grew 18.9%, EPS grew 81.3%, free cash flow grew 19.1% and total debt fell 25.9%, each against the same quarter a year earlier. Revenue growth for three consecutive years, operating cash flow growth for three; insiders bought in the last twelve months.

16.51 0.22 −1.32%

Follow AUPH

Alert me

Market cap: $2.2B
P/E: 6.9×
Fwd P/E: 16.5×
Dividend yield: —
F-score: 8/9
Altman Z: 7.86
Beneish M: −0.88
Dividend safety: n/a

Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

	Jun '26	Mar '26	Dec '25	Sep '25	Older periods
P/E ratio Full definition →	7.10	6.56	7.35	19.05	+8 more quarters Free account
P/S ratio Full definition →	7.09	6.58	7.57	5.48
P/FCF ratio Full definition →	12.61	11.77	15.83	12.15
P/Operating CF Full definition →	41.99	60.25	46.93	32.77
P/B ratio Full definition →	3.59	3.46	3.69	3.98
Price to Tangible BV Full definition →	3.61	3.48	3.71	4.02
EV/Sales Full definition →	5.81	5.47	6.35	4.37
EV/EBITDA Full definition →	11.30	10.93	13.42	11.66
EV/Operating CF Full definition →	10.32	9.77	13.25	9.66
EV/FCF Full definition →	10.33	9.79	13.27	9.68
Quick Ratio Full definition →	4.85	4.94	4.69	5.02
Current Ratio Full definition →	5.42	5.55	5.25	5.76
Net Debt/EBITDA Full definition →	(8.88)	(7.11)	(10.47)	(8.33)
Debt/Assets Full definition →	5.55%	6.65%	6.96%	10.56%
Debt/Equity Full definition →	0.07	0.08	0.09	0.15
Asset Turnover Full definition →	0.48	0.49	0.43	0.49
Operating CF/Net income Full definition →	1.41	0.95	0.22	1.41
Capex/Depreciation Full definition →	0.00	(0.01)	(0.01)	(0.01)
Interest Coverage Full definition →	42.31	41.21	26.90	27.91
Research and Development Expense of Revenue Full definition →	15.68%	9.61%	14.13%	11.48%
Selling, General and Administrative Expense of Revenue Full definition →	28.25%	28.35%	37.94%	35.64%
Intangible Assets out of Total Assets Full definition →	0.00	0.01	0.01	0.01
Share Based Compensation of Revenue Full definition →	3.41%	(1.11%)	8.72%	8.06%
Graham Net Nets Full definition →	0.16	0.17	0.15	0.19
Graham Number Full definition →	15.94	14.77	14.53	6.02
Earnings Yield Full definition →	14.08%	15.25%	13.61%	5.25%
Free Cash Flow Yield Full definition →	7.93%	8.49%	6.32%	8.23%
Revenue per Share Full definition →	0.64	0.59	0.57	0.56
Operating CF per Share Full definition →	0.40	0.25	0.34	0.34
Capex per Share Full definition →	0.00	0.00	0.00	0.00
Free Cash Flow per Share Full definition →	0.40	0.25	0.34	0.34
Cash per Share Full definition →	3.41	2.86	2.96	2.67
Shareholders Equity per Share Full definition →	4.73	4.29	4.33	2.78
Interest Debt per Share Full definition →	0.00	0.00	0.00	0.00
Book value per Share Full definition →	4.73	4.29	4.33	2.78
Free Cash Flow Full definition →	52.57	32.52	45.60	44.38
Working Capital Full definition →	441.43	393.69	398.24	362.52
Capital Expenditures Full definition →	0.00	(0.04)	(0.07)	(0.06)
Net Current Asset Value Full definition →	363.93	323.87	321.71	276.98
EV/EBIT Full definition →	12.86	12.56	15.71	14.49
Capex to Sales Full definition →	0.00	0.00	0.00	0.00
Price to Operating Income Full definition →	15.70	15.11	18.73	18.18
Other line items
Average Receivables Full definition →	40.61	44.76	39.00	33.61
Average Payables Full definition →	2.52	3.44	4.25	29.49
Average Inventory Full definition →	45.83	46.30	42.46	41.75
Average Assets Full definition →	647.41	614.42	651.12	538.44
Average Common Equity Full definition →	475.08	458.91	479.40	376.89

Show all line items

Columns are period end dates

Stockrow Weekly